期刊文献+

阿塞那平(asenapine) 被引量:3

原文传递
导出
作者 惠子 董金华
机构地区 沈阳药科大学
出处 《中国药物化学杂志》 CAS CSCD 2010年第2期156-156,共1页 Chinese Journal of Medicinal Chemistry
  • 相关文献

参考文献4

  • 1KEMPERMAN G J, STUK T L, LINDEN VAN DER J J M. Process for the preparation of asenapine and intermediate products used in said process: CN, 101484456 [ P]. 2009 - 07 - 15.
  • 2王维奇,池本哲哉. Method for producing dibenzoxepinopyrrole compound and its intermediate,and new intermediate:JP, 2007137877A[ P]. 2007 -06 -07.
  • 3德田修,王维奇,池本哲哉.阿塞那平合成中间体的制备方法:CN,1015633212A[P].2009-10-21.
  • 4SHAHID M, WALKER G B, ZOM S H, et al. Asenapine: a novel psychopharmacologic agent with a unique human receptor signature[ J]. J Psyehopharmacol,2009,23( 1 ) :65 - 73.

同被引文献15

  • 1VADER J,ASPERSEN F,AGENAARS G.The syntheses of radiolabelled org 5222 and its main metabolite org5526[J].J Labelled Compd Radiopharm,1994,34(9): 845-867.
  • 2KEMPERMAN GJ,STUK TL.Process for the preparation of asenapine and intermendiate products used in said process: WO,2008003460[P].2008-01-10.
  • 3CZARNIK AW,RENON V.Deuterium-enriched asenapine: US,20090209608A1[P].2009-08-20.
  • 4HARRIS TW,SMITH HE,MOBLEY PL,et al.Affinity of 10-(4-methylpiperazino) dibenz[b,f]oxepins for clozapine and spiroperidol binding sites in rat brain[J].J Med Chem,1982,25(7): 855-858.
  • 5LINDEN MVD,ROETERS T,HARTING R,et al.Debottlenecking the synthesis route of asenapine[J].Org Process Res Dev,2008,12(2): 196-201.
  • 6FUNKE CW,HINDRIKS H,SAM AP.Physico-chemical properties and stability of trans-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1H-dibenz[2,3:6,7]oxepino[4,5-c]pyrrolidine maleate[J].Arzneimittelforschung,1990,40(5):536-539.
  • 7MENASRA H,KEDJADJA A,DEBACHE S,et al.Efficient synthesis of 3-pyrrolylquinolines via an 1,3-dipolar cycloaddition/oxidation Sequence[J].Synth Commun,2005,35(21): 2779-2788.
  • 8LINK JT,DANISHEFSKY SJ.Regioselective imide reduction: an issue in the total synthesis of staurosporine[J].Tetrahedron Lett,1994,35(49): 9135-9138.
  • 9VADER J, AEPERSEN F, AGENAARS G. The synthesis of radiola- belled org 5222 and its main metabolite org5526[J]. J. Labelled Com- pd Radiopharm, 1994, 34(9): 845-867.
  • 10KEMPERMAN GJ, STUK TL. Process for the preparation of asenapine and intermediate products used in said process [P]. WO: 2008003460,2008-01-10.

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部